U.S. FDA Approves Akebia’s Vadadustat For CKD-induced Anemia
-
Drug News
U.S. FDA Approves Akebia’s Vadadustat For CKD-induced Anemia
On March 27, the U.S. Food and Drug Administration (FDA) granted approval to Akebia Therapeutics’ (AKBA.O) drug, vadadustat, for the…
Read More »
